Results 171 to 180 of about 3,149,992 (309)

Aerosolized antifungal therapy in pulmonary fungal disease: pharmacology, drug delivery and emerging clinical applications. [PDF]

Front Med (Lausanne)
Caracciolo M, Caracciolo SA, Stagno MF, Pellicano S, Ripepi A, Pellicano N, Scopelliti C, Serranò AE, Loddo A, Scala S.   +9 more
europepmc   +1 more source

AI‐Assisted Fungal Detection in Dermatopathology: A Study on Accuracy, Efficiency, and Usability

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives AI‐based image analysis is increasingly applied in pathology. Excluding fungal elements in PAS‐stained skin sections is labor‐intensive and well suited for AI assistance. While fungal detection in nails has been studied, skin‐biopsy applications and real‐world benefit remain limited.
Paul Schmidle, Tobias Lang, Sebastian Springenberg, Diego Calvopiña, Theresa Köhler, Valentina Getova, Ana‐Maria Gebing, Sonja Hetzer, Johanna Pierrone, Valentin Aebischer, Dieter Metze, Almut Böer‐Auer, Stephan Alexander Braun   +12 more
wiley   +1 more source

Gas6/Axl-mediated macrophage hyporesponsiveness drives severe pulmonary mucormycosis in diabetic mice. [PDF]

Front Cell Infect Microbiol
Kondo S, Owaki K, Hamasaki G, Inukai T, Kinoshita J, Ito T, Nakamura S, Shibata T.   +7 more
europepmc   +1 more source

ANZTCT cytomegalovirus practice survey for allogeneic haemopoietic stem cell transplant and cellular therapy recipients in Australia and New Zealand

Internal Medicine Journal, EarlyView.
Abstract Background Despite pre‐emptive treatment (PeT), cytomegalovirus (CMV) disease and reactivation remain a clinical concern. In Australia and New Zealand (ANZ), variability exists in the management of CMV for haematopoietic stem cell transplantation (HSCT) recipients.
Andrea Henden, Lynette Chee, Julia Clark, Rachel Conyers, Julian Cooney, Richard Doocey, David Gottlieb, Tim Prestidge, Madeleine Powys, Philip Selby, Gaurav Sutrave, Eric Wong, Michelle K. Yong, Nada Hamad   +13 more
wiley   +1 more source

Outpatient Treatment with Isavuconazole for Recurrent Chronic Cavitary Pulmonary Aspergillosis in a Residual Post-Lobectomy Cavity: A Case Report. [PDF]

Infect Dis Rep
Valente M, Fumagalli G, Caputo V, Riccardi N, Allavena L, Ferrarese M, Codecasa LR.   +6 more
europepmc   +1 more source

Preventing infections after CD19‐directed chimeric antigen receptor T‐cell therapies for lymphoma: a consensus practice statement

Internal Medicine Journal, EarlyView.
Abstract Chimeric antigen receptor (CAR) T‐cell therapies directed against cluster of differentiation 19 (CD19) are a standard of care for relapsed or refractory B‐cell lymphomas. Infection is the leading cause of non‐relapse mortality, and this risk may persist for years after CAR T‐cell receipt.
Aine Hurley, Philip George, Gemma Reynolds, Adam Stewart, Hang Quach, Nicole O'Leary, Zoe McQuilten, Andrea S. Henden, Lynette Chee, Chan Y. Cheah, Olivia Bupha‐Intr, Emily Blyth, Ben Teh, Monica Slavin, Michael Dickinson, Robert Weinkove   +15 more
wiley   +1 more source

Diagnostic Reassessment of a Pulmonary Mass Initially Suspected to Represent IgG4-Related Lung Disease: The Complementary Role of Tissue Metagenomic Sequencing. [PDF]

Diagnostics (Basel)
Kim SY, Lee JE, Lee DH, Kim HY, Kim KH, Jeong H, Chung C.   +6 more
europepmc   +1 more source

Erythrocyte ‘Feierzeit’ reaction: Novel filamentous and vesicular response to n‐butyl acetate

Journal of Microscopy, EarlyView.
Abstract Human erythrocytes (red blood cells; RBCs) undergo spontaneous disassembly after several hours of exposure to n‐butyl acetate (nBA). Images of the morphological changes were captured in time‐lapse sequences using differential interference contrast (DIC) light microscopy.
Philip W. Kuchel
wiley   +1 more source

Rare clinical presentation of invasive pulmonary aspergillosis in patient with early-stage lung cancer: a case report. [PDF]

Front Med (Lausanne)
Adzić-Vukicevic T, Dalifi S, Petkovic K, Savic M, Lukic K, Sobic-Saranovic D, Salmanton-García J.   +6 more
europepmc   +1 more source

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

, 2008
Background. Invasive fungal diseases are important causes of morbidity and mortality. Clarity and uniformity in defining these infections are important factors in improving the quality of clinical studies.
WALSH TJ, KAUFFMAN CA, DENNING DW, ODDS FC, RESTREPO A, EDWARDS JE, HERBRECHT R, CALANDRA T, EORTCMSG CONSENSUS GROUP, PATTERSON TF, KULLBERG BJ, RUHNKE M, MAERTENS J, ZAOUTIS T, DE PAUW B, DISMUKES WE, SORRELL, TC, HOPE WW, RESEARCH AND TREATMENT OF CANCERINVASIVE FUNGAL INFECTIONS COOPERATIVE GROUP, PERFECT JR, KIBBLER CC, STEVENS DA, WINGARD JR, BENNETT JE, LORTHOLARY O, MUÑOZ P, SEGAL BH, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES MYCOSES STUDY GROUP, SOBEL JD, EUROPEAN ORGANIZATION FOR, DONNELLY JP, MASCHMEYER, G, VISCOLI, CLAUDIO, MARR KA, BILLE J, PAPPAS, PG   +35 more
core